Navigation Links


Express in Medical Technology

International Medical Corps Matched with Top 25 American Express Members Project, 'Saving the Lives of Malnourished Children'

LOS ANGELES, Sept. 24 /PRNewswire-USNewswire/ -- International Medical Corps was selected by American Express to implement one of the Top 25 Members Projects, 'Saving the Lives of Malnourished Children.' ( http://www.membersproject.com/project/view/OZH1P1 ) The project was chosen out of 1,190 ...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...king Statements This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or con...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...ject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays. ...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

...at product to the Global Fund to finance AIDS programs in Africa, with an emphasis on the health of women and children. Current partners are: American express (U.K. only), Apple, Converse, Gap, Emporio Armani, Hallmark, Dell, Windows and Starbucks. Since its launch in the Spring of 2006, more than $130 milli...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...ulin M (IgM), an important gene for rat antibody production. Inactivation of rat IgM expression is the first step in generating rats that exclusively express human antibodies encoded by transgenic human immunoglobulin genes. "Creating a knockout rat was the biggest challenge OMT faced," said Dr. Roland Bue...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

...g statements that can be identified by terminology such as "may," "will," "risk," "estimated," "committed," "potential," or similar expressions, or by express or implied discussions regarding potential future indications or labeling for Tekturna or Tekturna HCT, or regarding potential future revenues from Te...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...identified by the use of forward-looking terminology such as "expect," "plans," "anticipates," "will," "expects," "goal" or similar expressions, or by express or implied statements with respect to the company's clinical development programs or commercialization activities in hepatitis C, or any potential pip...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...tissue-derived stem cell treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy utilizing autologous cells that are genetically modified to express additional potentially therapeutic growth proteins. For more information on Bioheart, visit www.bioheartinc.com . Forward-Looking Statements...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...ward-looking statements that can be identified by terminology such as "potential," "may," "risk," "will," "potentially," or similar expressions, or by express or implied discussions regarding potential new marketing approvals, or new indications or labeling for Afinitor or regarding potential future revenues...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

...look forward to," "risk," "suggests," "potentially," "in development," "may," "pipeline," "being studied," "strategies," or similar expressions, or by express or implied discussions regarding potential future marketing approvals for compounds in development, potential new indications or labeling for existing...

Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma

...pany's web site at http://www.agennix.com . Forward Looking Statements This press release contains forward-looking statements, which express the current beliefs and expectations of the management of Agennix. Such statements are based on current expectations and are subject to risks and unc...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

...t lower restenosis rate at two years compared to the prior-generation TAXUS express Stent. The authors concluded that "There seem to be important differences ...newer and thinner-strut TAXUS Liberte Stent performed better than the TAXUS express Stent in reducing restenosis." The Swedish registry study included fo...

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

... The one-year results demonstrated that the TAXUS express Stent significantly reduced angiographic restenosi...ety measure showed no difference between the TAXUS express Stent and the bare-metal express Stent in overall major adverse cardiovascular even...

First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept

...of small, novel oncolytic peptides to selectively destroy cancer cells that express target receptors. In addition to EP-100, the Company is developing several ...n whereby candidates bind specifically and exclusively to cancer cells that express the target receptors on their surfaces. The positively charged peptides dis...

NewCardio Leadership to Present Two Abstracts at ISCE Conference

... Statements This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or con...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

... be identified by terminology such as "risk," "options," "potential," "continue to study," "explore," "estimated," "can" or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Afinitor, potential approvals of Afinitor in additional markets, or regardi...

Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms

... companies. The SPIRIT Clinical Program is sponsored by Abbott. The TAXUS express Stent was the control in the SPIRIT III trial and both the TAXUS express Stent (59 patients) and the TAXUS Liberte Stent (17 patients) were used as ...

Drug Development Program Started Based on CAP(R) Human Cell Line

...t is to develop a recombinant human alkaline phosphatase (rhuAP) using the novel versatile human CAP(R) cell line, which has been shown to efficiently express glycosylated proteins. The rhuAP produced in CAP(R) cells is expected to feature improved pharmacokinetic and safety profile allowing for repeated dos...

GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA

...eoVax's DNA and MVA vaccines are used in a prime-boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. These particles contain proteins that...

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

...ard-looking statements that can be identified by terminology such as "anticipate," "will," "might," "encouraging," "may" or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Zometa or regarding potential future revenues from Zometa. You should not p...

EntreMed Presents Initial Clinical Results for ENMD-2076

...multi-drug resistant, triple-negative human breast carcinoma model. Triple-negative breast cancer is a specific subtype of breast cancer that does not express estrogen receptor, progesterone receptor, or Her2 genes. This subtype is more aggressive and less responsive to standard treatment and is also associa...

Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV

...ing statements can be identified by the use of forward-looking terminology such as "anticipate," "could," "may," "will," or similar expressions, or by express or implied statements with respect to the company's clinical development programs in HIV, or any potential pipeline candidates for the treatment of HI...

Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents

...ts with Boston Scientific's first-generation TAXUS express Stent. While the second-generation TAXUS Liberte ...ug dose, polymer and release kinetics as the TAXUS express Stent, it features thinner struts and a uniform ar...nth, in-segment diameter stenosis versus the TAXUS express Stent control group. They reported a significant ...

RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

...ology such as "promising," "will," "potential," "may," "committed," "exploring," "believed," "estimated," "anticipated," or similar expressions, or by express or implied discussions regarding potential regulatory filings or marketing approvals for RAD001 or regarding potential future revenues from RAD001. Yo...

New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors

... release contains forward-looking statements that can be identified by terminology such as "risk," "suggested," "could," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Sandostatin LAR, potential future approvals for RAD001, or regarding potent...

Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer

...aking it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the GM-CSF protein. GM-CSF complements the cancer cell lysis work of the product candidate, leading to a cascade of events resulting in tumor necrosis...

Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...ng statements can be identified by the use of forward-looking terminology such as "may," "plans," "anticipates," "will," or similar expressions, or by express or implied statements with respect to the company's clinical development programs or commercialization activities in hepatitis C, or any other potenti...

RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

... start," "to explore," "may," "to fully explore," "promising," "encouraged," "committed," "will," "to further evaluate," or similar expressions, or by express or implied discussions regarding potential regulatory filings or marketing approvals for RAD001 or regarding potential future revenues from RAD001. Yo...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

...ing. MammaPrint's ability to accurately determine high risk patient responsiveness to chemotherapy both confirm and speak to the confidence physicians express in this state-of-the-art genomic breast cancer test," commented Dr. Richard Bender, Chief Medical Officer of Agendia and a life-long practicing oncolo...

Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery

...ied by terminology such as "risk," "suggested," "suggest," "potential," "may," "explore," "promise," "estimate," "will," or similar expressions, or by express or implied discussions regarding potential new indications or labelling for Femara or regarding potential future revenues from Femara. You should not ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

...ase contains forward-looking statements that can be identified by terminology such as "suggesting," "may," "commitment," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Tasigna, the long-term impact of a patient's use of Tasigna or regarding po...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

...fied by terminology such as "potential," "pipeline," "to be," "to show," "can," "to report," "to affirm," "will," "may," or similar expressions, or by express or implied discussions regarding potential new products, potential new indications for existing products, or regarding potential future revenues from ...

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America

...x HIV-1 DNA vaccine which "primes" the immune system followed by the second vaccine, GeoVax's HIV-1 MVA (Modified Vaccinia Virus) boost. Both vaccines express the three major proteins of the AIDS virus. These proteins mimic more than 50% of the components of the AIDS virus (HIV-1) but cannot cause AIDS. GeoV...

Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483

...3 Factor VII is a blood protein involved in clotting. Many types of cancer, such as lung, breast, pancreatic, colorectal, gastric and others, express high levels of a cell surface protein known as tissue factor (TF). After binding to TF, Factor VII becomes activated and triggers a host of pathologic...

Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!'

...oking statements that can be identified by terminology such as "will", "committed", "potentially", "hope", "can", "may", or similar expressions, or by express or implied discussions regarding potential future revenues from the "Let's Fight Flu Together!" campaign. You should not place undue reliance on these...

Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

...rminology such as "potential", "planned", "plans", "seeking", "can", "estimated", "could", "potentially", "will", "may", or similar expressions, or by express or implied discussions regarding potential new indications or labelling for Xolair, or potential future revenues from Xolair. You should not place und...

HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients

...ercent reduction in revascularization in the TAXUS express group (7.5 percent for the express Stent versus 4.5 percent for the TAXUS express Stent, p=0.002). "Our investments in drug-elutin...

Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent

... TAXUS Liberte Stent vs. 9.6 percent for the TAXUS express control stent (p=0.81). Three-year data also showe... TAXUS Liberte Stent vs. 2.3 percent for the TAXUS express Stent, p=0.20) and overall myocardial infarction (... TAXUS Liberte Stent vs. 6.3 percent for the TAXUS express Stent, p=0.36). The adjusted rate of ARC definite/...

Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008

...ts from the ARRIVE diabetic subset analysis (TAXUS express Stent), three-year data from the ATLAS Workhorse a...s non-inferior in safety and efficacy to the TAXUS express Stent. The Company plans to issue a press release ...meter. The safety and effectiveness of the TAXUS express Stent has not been established in patients with le...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

...rther explore," "promising," "suggest," "expected," "promise," "can," "goal," "prognosis," "will," "plans," "estimated," or similar expressions, or by express or implied discussions regarding potential new indications or labelling for Gleevec, regarding potential future revenues from Gleevec, or regarding th...
Other TagsbeescodecodecodecodecodedatadatadatadatadatadatadataoldoldoldoldoldoldoldUnveilsUnveilsTestTestTestTestTestTestTestTestLookLookLookLookmenmenmenmenmenmenmenmenmenreducesreducesreducesMaleMaleMaleRSVOther Contentsdigitaldigitaldigitaldigitaldigitaldigitaldigitaldimerdimerdimerdisulfidedisulfidedisulfidehelixhelixhelixhelixhelixdoubledoubledoubledoubledoubledoubledoubledoubledoubledowndowndowndowndowndowndowndowndowndowndrugdrugdrugdrugdrugdrugdrugdrugdrugdrug